Xcout Intel
immunitoAI
immunitoAI is a TechBio research company founded in 2020 that develops AI-driven platforms to unlock the potential of antibody therapeutics. Headquartered in Bengaluru, Karnataka, India, the company employs a team of 11 to 50 professionals.
Subscribe to see immunitoAI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
immunitoAI at a glance
immunitoAI is a biotechnology company headquartered in India. It has raised at least $7.1M across the 2 funding rounds on record. Its most recent funding round, Seed, raised $6.1M in November 2025. Xcout tracks 4 named people at immunitoAI, including Dr. Abhishek Mathur (CSO).
immunitoAI leadership
- Dr. Abhishek MathurCSO
- Dr. Aridni ShahCo-Founder and CEO
- Trisha ChatterjeeCo-Founder and CTO
- Aridni ShahCo-Founder
immunitoAI funding rounds
At least $7.1M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $6.1M | 4 named | |
| — | $1M | 9 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
immunitoAI competitors
A few of immunitoAI's closest competitors — see the full list of competitors and alternatives →
Prellis Biologics, Inc. is a privately held biotechnology company headquartered in Berkeley, California, within the San Francisco Bay Area. It develops human antibody therapeutics and focuses on antibody discovery leveraging AI and immune diversity.
Biolojic Design is an Israeli biotechnology company that uses computational modeling and artificial intelligence to design and engineer antibodies and other therapeutic proteins. It develops drug candidates and collaborates with pharmaceutical and biotechnology companies seeking novel biologic medicines.
Monocacy Therapeutics Inc. develops artificial intelligence-guided, first-in-class immune medicines designed to restore optimal immune function and patient health. The company utilizes a full-stack, AI-powered immunology platform to discover and develop next-generation immunotherapies for patients.
Antiverse is a biotechnology research company headquartered in Cardiff, Wales, that utilizes generative artificial intelligence to design functional antibodies for challenging drug targets.
CombinAble.AI is an Israeli biotechnology startup incubated within AION Labs that develops a novel approach to biological drug discovery through the design and optimization of antibodies. The company leverages artificial intelligence to accelerate the development process for biological therapeutics and was acquired by Insitro.
Pathos AI, Inc. is an artificial-intelligence-driven biopharmaceutical company that uses multimodal patient and biological data to discover and develop precision medicines. Its work is focused primarily on oncology and serves patients with serious diseases through pharmaceutical and healthcare partnerships.
Get immunitoAI's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on immunitoAI in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access